Baxdrostat/Placebo clinical trials

A Phase IIb Study to Evaluate the Effect of Dapagliflozin in Combination With Baxdrostat Compared With Baxdrostat on Albuminuria in Participants With Chronic Kidney Disease and High Blood Pressure.

This study looks at a new combination of two medicines, baxdrostat and dapagliflozin, for people with lasting kidney disease and high blood pressure. We want to see if this combination can lower a protein called albumin in the urine, which is a sign of kidney damage.